Post-neoadjuvant treatment of breast cancer by V. F. Semiglazov, M. A. Dzhelialova, S. S. Yerechshenko, E. T. Munaeva, R. S. Pesotsky, A. I. Tseluyko, A. S. Emelyanov, R. V. Donskikh, P. V. Krivorotko

Subjects: Get full text

Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021 by Dario Trapani, Giuseppe Curigliano

Subjects: Get full text

Treatment Strategies for Residual Disease following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer by Hikmat Abdel-Razeq, Hanan Khalil, Hazem I. Assi, Tarek Bou Dargham

Subjects: Get full text

Strategy of post-neoadjuvant treatment of patients with residual breast cancer by V. V. Semiglazov, A. A. Natopkin

Subjects: Get full text

Key studies that have changed the history and treatment of early HER2+ breast cancer: focus on individual therapy by I. V. Kolyadina, I. V. Poddubnaya

Subjects: Get full text